Evaxion A S Adr (EVAX)

11:53 AM

Evaxion Biotech price target raised to $16 from $14 at H.C. Wainwright - TipRanks

11:53 AM

07:44 AM

Evaxion Biotech out-licensed vaccine candidate EVX-B3 to MSDMerck - TipRanks

07:44 AM

Sep 16, 2025

Evaxion A/S (NASDAQ:EVAX) Trading Down 0.7% – Should You Sell? - Defense World

Sep 16, 2025

Aug 31, 2025

Evaxion Biotech A/S Adr Earnings Call: Strategic Growth Amid Challenges - TipRanks

Aug 31, 2025

Aug 28, 2025

Evaxion Biotech Reports Q2 2025 Financial Results - MSN

Aug 28, 2025

Aug 26, 2025

Untreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight - GlobeNewswire Inc.

Aug 26, 2025

Aug 21, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week - MSN

Aug 21, 2025

Aug 17, 2025

XTX Topco Ltd Makes New Investment in Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) - Defense World

Aug 17, 2025

Aug 04, 2025

Short Interest in Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Expands By 148.8% - Defense World

Aug 04, 2025

Jul 12, 2025

Evaxion Boosts Equity through Debt Conversion, Improves Financial Flexibility - AInvest

Jul 12, 2025

Jul 11, 2025

Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest

Jul 11, 2025

Jul 04, 2025

Biotech Contrarians: Seizing Value in Europe's ADRs Amid Sectoral Slump - AInvest

Jul 04, 2025

Jun 21, 2025

European ADRs Dip As Evaxion And Grifols Climb - Finimize

Jun 21, 2025

Jun 18, 2025

European ADRs Dip While Biotech And Energy See Gains - Finimize

Jun 18, 2025

Jun 03, 2025

EVAX: Grant For Polio Vaccine Announced - Research Tree

Jun 03, 2025

May 31, 2025

Evaxion Biotech’s Earnings Call Highlights Progress and Challenges - MSN

May 31, 2025

May 27, 2025

Evaxion Biotech Reports Q1 2025 Progress and Financials - TipRanks

May 27, 2025

May 27, 2025

European ADRs Rise On S&P Europe Select Index - Finimize

May 27, 2025

May 15, 2025

European Equities See Growth In US Trade - Finimize

May 15, 2025

Apr 28, 2025

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - GlobeNewswire Inc.

Apr 28, 2025

Apr 28, 2025

Evaxion’s EVX-01 vaccine shows promising immune response in trial - Investing.com

Apr 28, 2025

Apr 24, 2025

European Equities Traded in the US as American Depositary Receipts Sharply Higher in Wednesday Trading - MSN

Apr 24, 2025

Apr 07, 2025

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - TradingView

Apr 07, 2025

Apr 04, 2025

European Stocks Slip In US Trading With Mixed Performances - Finimize

Apr 04, 2025

Apr 02, 2025

Evaxion Biotech’s Optimistic Earnings Call Highlights - TipRanks

Apr 02, 2025

Apr 02, 2025

Evaxion Biotech Reports 2024 Financial Results and Strategic Progress - TipRanks

Apr 02, 2025

Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025

Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025

Mar 25, 2025

Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline - Investing.com

Mar 25, 2025

Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025

Mar 10, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - TradingView

Mar 10, 2025

Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025

Mar 04, 2025

Evaxion Biotech stock hits 52-week low at $1.79 amid market challenges - Investing.com

Mar 04, 2025

Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025

Feb 26, 2025

EVAX: Extended Trial is Excellent News - Research Tree

Feb 26, 2025

Feb 25, 2025

Evaxion Biotech stock hits 52-week low at $2.22 amid sharp decline - Investing.com

Feb 25, 2025

Feb 14, 2025

Evaxion secures Nasdaq listing with equity boost - Investing.com

Feb 14, 2025

Feb 03, 2025

H.C. Wainwright maintains Evaxion stock Buy rating, $14 target - Investing.com

Feb 03, 2025

Jan 30, 2025

Evaxion Biotech stock hits 52-week low at $2.38 amid market challenges - Investing.com

Jan 30, 2025

Jan 17, 2025

Evaxion Biotech stock hits 52-week low at $3.06 amid sharp decline - Investing.com

Jan 17, 2025

Jan 14, 2025

Evaxion Biotech Completes 1:5 Reverse ADS Split: What Investors Need to Know - Stock Titan

Jan 14, 2025

Jan 10, 2025

Evaxion Biotech stock hits 52-week low at $0.81 amid market challenges - Investing.com

Jan 10, 2025

Dec 30, 2024

Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - Nasdaq

Dec 30, 2024

Dec 26, 2024

Evaxion Biotech stock hits 52-week low at $0.84 amid market challenges - Investing.com

Dec 26, 2024

Dec 17, 2024

Evaxion Biotech stock hits 52-week low at $0.92 - Investing.com

Dec 17, 2024

Aug 14, 2024

Earnings call: Evaxion Biotech reports Q2 results, optimistic on EVX-01 - Investing.com

Aug 14, 2024

Apr 03, 2024

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data - Yahoo Finance

Apr 03, 2024

Jan 19, 2024

European Equities Traded as American Depositary Receipts Down Fall - TradingView

Jan 19, 2024

Jun 08, 2022

Bears are Losing Control Over Evaxion Biotech AS Sponsored ADR (EVAX), Here's Why It's a 'Buy' Now - Nasdaq

Jun 08, 2022

Nov 05, 2021

Evaxion Biotech (EVAX) Stock Price Fell 44% Premarket After Discounted Share Issue - AskTraders.com

Nov 05, 2021

Nov 04, 2021

Evaxion Biotech (EVAX) Stock Price Soared 236.9% Premarket Amid Buying Pressure - AskTraders.com

Nov 04, 2021